Research Update
Research Update RSS Feed RSS

RESEARCH UPDATE

New Canadian Eating Disorders Guidelines

March 12, 2021
John Raiss, MD
John Raiss, MD Dr. Raiss has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
What is the best approach to treatment of adolescents with eating disorders? What level of care should be we advocating for to have the best chance of a good outcome? This review of the recent Canadian Eating Disorders Guidelines offers a clear direction for our efforts to provide better care.
Read More
RESEARCH UPDATE

Beta Blockers and Depression: The Controversy Revisited

December 31, 2020
Sean Ransom, Ph.D
Sean Ransom, Ph.D Dr. Ransom has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
There is an age-old debate about whether blood pressure medications cause depression. This study is one of the largest to tackle the issue, and it suggests this risk may be limited to one class of antihypertensives in particular.
Read More
RESEARCH UPDATE

Beta Blockers and Depression: The Controversy Revisited

November 12, 2020
Sean Ransom, PhD, MP.
Sean Ransom, PhD, MP. Dr. Ransom has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Antihypertensives are among the world’s most widely prescribed drugs, but many of them impact pathways associated with depression. Beta blockers have long been believed to cause depression, but most of these studies were carried out decades ago and their findings have been inconsistent.
Read More
RESEARCH UPDATE

Two Augmentation Strategies Compared in Bipolar I

September 3, 2020
Richard Moldawsky, MD

Richard J. Moldawsky, MD. Dr. Moldawsky has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Carbamazepine or valproic acid? Both have been used to augment lithium for decades, but which one works best? A new trial tests them head-to-head.
Read More
RESEARCH UPDATE

Olanzapine for Anorexia Nervosa

November 15, 2019
Kristen Gardner, PharmD.
Kristen Gardner, PharmD. Dr. Gardner has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
A randomized, double- blind, placebo-controlled trial studying the effects of olanzapine on change in body weight and obsessionality in adult outpatients with anorexia nervosa. Although strength of the study includes its large sample size, it is undetermined if patient weight gain is due to a therapeutic effect on anorexia or to olanzapine’s known metabolic effects.
Read More
RESEARCH UPDATE

Can Mindfulness-Based Stress Reduction Affect Symptom Outcomes in Older Adults?

December 1, 2017
Adam Strassberg, MD.
Adam Strassberg, MD. Dr. Strassberg has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Mindfulness-based stress reduction (MBSR) is a formalized combination of mindfulness meditation, body awareness, and yoga. The technique has been shown to help with symptoms of depression and anxiety, and some preliminary small studies have hinted that it might improve both memory and anxiety/depressive symptoms in older patients.
Read More
RESEARCH UPDATE

Psychedelic Mushrooms May Help Treatment Resistant Depression

June 1, 2016
Bret A. Moore, PsyD, ABPP
Bret A. Moore, PsyD, ABPP

Board-Certified Clinical Psychologist, San Antonio, TX

Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Psilocybin, a naturally occurring and psychedelic compound of the Psilocybe species of mushrooms, has garnered the most attention.
Psilocybin is essentially a serotonin 2A agonist. Theoretically, this action should mediate depressive symptoms, but we don’t know for sure because no available antidepressants are direct agonists of this receptor. Researchers from the United Kingdom set out to see if this is indeed the case.
Read More
RESEARCH UPDATE

Good News for Smoking Cessation Drugs: Not as Scary as Once Thought

June 1, 2016
Bret A. Moore, PsyD, ABPP

Bret A. Moore, PsyD, ABPP                                    

Board-Certified Clinical Psychologist, San Antonio, TX.                                       

Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Both varenicline (Chantix) and bupropion (Zyban) are effective anti-smoking agents, but over the years we’ve heard about potential neuropsychiatric side effects, especially related to varenicline. These include depression, suicidal thoughts, psychosis, and nightmares.
Read More
RESEARCH UPDATE

Synthetic THC and Antihypertensive Provide Little Benefit for Cannabis Dependence

May 1, 2016
Bret A. Moore, PsyD, ABPP
Bret A. Moore, PsyD, ABPP. Board-Certified Clinical Psychologist, San Antonio,.

Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Second only to alcohol, marijuana is the most common reason people enter substance abuse treatment. And unlike alcohol dependence, there are virtually no effective medications available for those addicted to it. It’s not from a lack of trying. A recent review of 14 drug studies for cannabis dependence revealed little benefit from antidepressants, anticonvulsants, or anxiolytics.
Read More
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
Featured Video
Featured Podcast
Recommended

About

Shop Online

Newsletters

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.